Nano-X Imaging
Nasdaq NNOX · Petach Tikva, Israel
Nano-X Imaging is a clinical trial sponsor based in Petach Tikva, Israel, listed as Nasdaq NNOX. It has 1 active clinical trial with 100 planned participants.
Trial track record · since 2021
Financials · Nasdaq NNOX
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Nano-X Imaging
Nano-X Imaging is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 100 planned participants. Since 2021 it has completed 0 trials and stopped 0 early.
Nano-X Imaging is based in Petach Tikva, Israel and is listed as Nasdaq NNOX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Nano-X Imaging; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-28.
Approve Suite is not affiliated with Nano-X Imaging.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.